FDA NDC Directory · JSON-LD · Markdown

Alrex

NDC 24208-353 · HUMAN PRESCRIPTION DRUG · SUSPENSION/ DROPS

Generic nameloteprednol etabonate
Labeler / ManufacturerBausch & Lomb Incorporated
Marketing categoryNew Drug Application (innovator) · App NDA020803
Dosage form / routeSUSPENSION/ DROPS · OPHTHALMIC
Active ingredientsLOTEPREDNOL ETABONATE (2 mg/mL)
Marketing started19980309
Package count3

External sources

Source: openFDA. Public-domain (CC0).